Deep Tech Startups

Cella accelerates the natural geologic process that turns carbon dioxide into a mineral by injecting captured atmospheric CO2 into volcanic rock, where mineralization permanently stores it underground. The company provides carbon storage technology designed to scale alongside carbon capture across varied geologic settings.

1 investor

Cellarim produces beauty and skincare ingredients using enzymatic, cell-free synthesis rather than extraction, fermentation, or conventional chemical methods. It positions its enzyme-based approach as a way to make purer, more scalable, and more sustainable cosmetic ingredients.

1 investor

CellBri provides modular, automated cell processing systems for preparing cells for therapeutic applications. The company offers enclosed, turnkey solutions that can automate individual steps or complete workflows, from cell harvesting and separation through expansion and cryopreservation.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.

1 investor

Cellfion develops materials for next-generation energy and water systems, focused on safer, higher-performance alternatives that reduce environmental impact. The company positions its work around sustainability and circular systems aligned with the UN Sustainable Development Goals.

1 investor

CeLLife Technologies develops battery testing and diagnostics technology that enables advanced data collection to assess battery quality, reduce scrapping of good cells, and extend battery life for manufacturers and energy storage operators. Founded as a spin-off from Tampere University, the company serves the battery production industry with a focus on European and global markets.

1 investor

Cellpurics is a contract research organization providing laboratory analysis services (such as real-time qPCR, Western blot, ELISA, flow cytometry, and pathology) and preclinical efficacy and safety testing for drug development. It also offers cosmetics efficacy evaluation, mesenchymal stem cell quality testing, and one-stop non-clinical to clinical services for veterinary drugs and medical devices.

1 investor

Cellular Highways manufactures the Highway1 Cell Sorter, a benchtop instrument for high-throughput cell sorting applications in research. The company serves life science researchers requiring fast, gentle cell sorting with high cell viability.

1 investor

CELUS provides AI-driven automation software for electronics engineering, helping engineers design and develop electronic circuits faster. It targets electronics design and hardware engineering teams.

1 investor

CEMWorks develops physics-based electromagnetic simulation software for electronic design automation (EDA), targeting engineers working on semiconductors, wireless systems (5G/6G), aerospace, automotive, and defense applications. Its tools model large-scale, high-frequency electromagnetic interactions to speed up design cycles for complex electronic systems.

1 investor

CENOS provides simulation software for practical engineers, focused on applications like induction heating, electromagnetics, and RFID/connectivity design. Its tools let engineers import CAD, set physics and materials, and run simulations to cut design cycles and reduce lab testing, serving manufacturing and R&D teams.

1 investor

Centera Photonics develops optical interconnect components and systems using wafer-level semiconductor process and optical system design, offering optoelectronic key components, total solutions, and customization. Its target markets include hyperscale and enterprise datacenters, cloud and high performance computing, storage, and consumer electronics.

1 investor

Centrillion develops high-density DNA chips combined with AI-powered analysis to generate genomic and cellular data at scale for biological research. The platform enables researchers to ask thousands of variant questions in a single assay and decode genomes, cells, and tissues using AI models.

1 investor

CERBAIR builds radiofrequency-based counter-drone systems for detecting, characterizing, and neutralizing malicious drones, serving armed forces, law enforcement, government sites, critical infrastructure, and large events. The French company deploys its systems in France and over 14 countries.

1 investor

Cerecura develops RNA therapies using LNP-RNA (lipid nanoparticle) technology to treat neurological and brain diseases. The company seeks collaborations with academic institutions, biotech companies, and pharmaceutical organizations to advance LNP-RNA therapeutics in neurology.

1 investor

Cerekon develops AI-driven computer vision and analytics solutions for industrial safety, inspection, and automation across construction, maritime, manufacturing, and supply chain sectors. The company integrates advanced AI with domain expertise to automate quality assurance, defect detection, and compliance monitoring in heavy industrial environments.

1 investor

Cereus Ultrasonics develops ultra-wideband active/passive sonar systems and high-power analogue components for interfacing piezo-electric transducers to power amplifiers in fluidic and high-pressure gas mediums. The company applies electro-acoustic techniques such as Acoustic Resonance Technology, including crack detection and condition measurement in gas pipelines.

1 investor

Cergentis provides genetic characterization and quality control services built on its Targeted Locus Amplification (TLA) technology platform, supporting the development of advanced therapies for pharma and biotech clients. Now part of Solvias, a CMC analytical services provider, it serves drug developers across the full development journey.

1 investor

Cesium is an open developer platform for building software applications with 3D geospatial data, providing visualization, data pipelines, curated data, and analytics. It includes a rendering engine and an implementation of 3D Tiles for streaming large datasets, serving developers across industries including government agencies and the U.S. Department of Defense.

1 investor

CESS is a team of cryptographers, data storage experts, and computer science engineers working on decentralized data storage solutions. The company operates globally with team members from the UK, USA, India, Hong Kong, UAE, and Argentina.

1 investor

CET evaluates early-stage biomedical technologies from researchers, universities and entrepreneurs and partners with them to support development and commercialization. It operates the CET Life Sciences Center, an incubator in Tennessee offering lab and office space and infrastructure for life sciences companies.

1 investor

Cetos Water develops advanced water treatment technology for desalination and brine management. The company commercializes thermally-driven solvent-based separation extraction (TSSE) technology to address hypersaline brine treatment and mineral recovery.

1 investor